Oxford, United Kingdom

Chiara Massarenti

This inventor holds 1 USPTO granted patent. Top assignees: Mayo Foundation for Medical Education and Research, Qlaris Bio, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chiara Massarenti. Retrieved from https://idiyas.com/inventor/chiara-massarenti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chiara Massarenti: Innovator in Controlled-Delivery Cromakalim Prodrugs

Introduction

Chiara Massarenti is a prominent inventor based in Oxford, GB. She has made significant contributions to the field of pharmacology, particularly in the development of controlled-delivery systems for therapeutic applications. Her innovative work has led to the creation of a patent that addresses critical medical needs.

Latest Patents

Chiara holds a patent for "Controlled-delivery cromakalim prodrugs." This invention provides cromakalim phosphate prodrugs, compositions, and their use for the modulation of ATP-sensitive potassium (K) channels for therapeutic purposes. This advancement has the potential to improve treatment options for various medical conditions.

Career Highlights

Throughout her career, Chiara has worked with notable organizations, including Qlaris Bio, Inc. and the Mayo Foundation for Medical Education and Research. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Chiara has collaborated with talented individuals such as Thurein M Htoo and Barbara M Wirostko. These partnerships have enriched her work and fostered an environment of innovation and discovery.

Conclusion

Chiara Massarenti's contributions to the field of controlled-delivery systems exemplify her dedication to advancing medical science. Her patent and collaborations highlight her role as a key innovator in pharmacology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…